Viral load monitoring in resource-limited settings: A medical and public health priority

AIDS

Volumn 26, Issue 13, 2012, Pages 1719-1720

  Ford, Nathan ^a,b   Roberts, Teri ^a   Calmy, Alexandra ^a,c  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

cost effectiveness; HIV; resource limited settings; viral load

Indexed keywords

ANTIRETROVIRUS AGENT;

COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DEVELOPING COUNTRY; DRUG TREATMENT FAILURE; EDITORIAL; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS LOAD;

ANTI-HIV AGENTS; COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; FEMALE; HEALTH PRIORITIES; HIV INFECTIONS; HIV-1; HUMANS; MALE; PUBLIC HEALTH; VIRAL LOAD;

EID: 84865385945     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283543e2c     Document Type: Editorial

References (18)

1. WHO. Scaling up antiretroviral therapy in resource-limited settings. Guidelines for a public health approach. Geneva: World Health Organization; June 2002. Available at http://www.who.int/hiv/pub/prev-care/ScalingUp-E.pdf [Accessed 11April 2012].
2. WHO. Scaling up antiretroviral therapy in resource-limited settings. Guidelines for a public health approach. Geneva: World Health Organization; 2003 Revision. Available at http://www.who.int/hiv/pub/prev-care/en/ arvrevision2003en.pdf [Accessed 11 April 2012]
3. WHO. Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach. Geneva: World Health Organization; 2010 Revision. Available at http://whqlibdoc.who.int/publications/2010/ 9789241599764-eng.pdf [Accessed 11 April 2012]
4. Hamers RL, Sawyer AW, Tuohy M, Stevens WS, Rinke de Wit T, Hill AM, the ART-A Consortium. Cost-effectiveness of laboratory monitoring for management of HIV treatment in sub-Saharan Africa: a model-based analysis. AIDS 2012; 26: 1663-1672.
5. Kasper T, Coetzee D, Louis F, Boulle A, Hilderbrand K. Demystifying antiretroviral therapy in resource-poor settings. Essent Drugs Monit 2003; 32:20-21.
6. Coetzee D, Boulle A, Hildebrand K, Asselman V, Van Cutsem G, Goemaere E. Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa. AIDS 2004; 18 (Suppl 3):S27-S31. (Pubitemid 39037456)
7. Walensky RP, Ciaranello AL, Park JE, Freedberg KA. Costeffectiveness of laboratory monitoring in sub-Saharan Africa: a review of the current literature. Clin Infect Dis 2010; 51: 85-92.
8. Gsponer T, Petersen M, Egger M, Phiri S, Maathuis MH, Boulle A, et al. The causal effect of switching to second-line ART in programmes without access to routine viral load monitoring. AIDS 2012; 26:57-65.
9. Keiser O, Chi BH, Gsponer T, Boulle A, Orrell C, Phiri S, et al. Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in Southern Africa. AIDS 2011; 25:1761-1769.
10. Orrell C, Harling G, Lawn SD, Kaplan R, McNally M, Bekker LG, et al. Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited. Antivir Ther 2007; 12:83-88. (Pubitemid 46340429)
11. Wilson D, Keiluhu AK, Kogrum S, Reid T, Seriratana N, Ford N, et al. HIV-1 viral load monitoring: an opportunity to reinforce treatment adherence in a resource-limited setting in Thailand. Trans R Soc Trop Med Hyg 2009; 103:601-606.
12. Ajose O, Mookerjee S, Mills EJ, Boulle A, Ford N. Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: a systematic review and metaanalysis. AIDS 2012 Feb 4 [Epub ahead of print].
13. Kahn JG, Marseille E, Moore D, Bunnell R, Were W, Degerman R, et al. CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study. BMJ 2011; 343:d6884.
14. Phillips AN, Pillay D, Miners AH, Bennett DE, Gilks CF, Lundgren JD. Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model. Lancet 2008; 371:1443-1451. (Pubitemid 351635534)
15. van Zyl GU, Preiser W, Potschka S, Lundershausen AT, Haubrich R, Smith D. Pooling strategies to reduce the cost of HIV-1 RNA load monitoring in a resource-limited setting. Clin Infect Dis 2011; 52:264-270.
16. Romih V, Zidovec Lepej S, Gedike K, Lukas D, Begovac J.Frequency of HIV-1 viral load monitoring of patients initially successfully treated with combination antiretroviral therapy. PLoS One 2010; 5:e15051.
17. JohannessenA, Troseid M, CalmyA. Dried blood spots can expand access to virological monitoring of HIV treatment in resourcelimited settings. J Antimicrob Chemother 2009; 64:1126-1129.
18. Murtagh M. HIV/AIDS diagnostic landscape. UNITAID technical report. Geneva: UNITAID; May 2011. Available at http://www.unitaid.eu/images/ marketdynamics/publications/v2-hiv diagxlandscape.pdf [Accessed 11 April 2012]